AmerisourceBergen

388 articles with AmerisourceBergen

• AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S.

  4/12/2021

  The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, announced today a $700,000 donation to Boys & Girls Clubs of America to support COVID-19 vaccine education and awareness in an effort to remove barriers to vital healthcare access.

• Xcenda’s FormularyDecisions Launches Resource Hub for Biosimilar Products

  4/8/2021

  As the demand for biosimilar product information continues to grow among payers, Xcenda’s FormularyDecisions—a secure online platform that facilitates information exchange between manufacturers and healthcare decision-makers—announced the launch of a Biosimilars Hub.

• AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release

  4/1/2021

  AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 5, 2021.

• AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031

  3/30/2021

  AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1,000,000,000 aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering.

• AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031

  3/25/2021

  AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1.0 billion aggregate principal amount of its 2.700% Senior Notes due March 15, 2031

• AmerisourceBergen Named Best Place to Work for LGBTQ Equality

  2/19/2021

  Company received 100 percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality

• AUA Announces Collaboration Agreement with IntrinsiQ Specialty Solutions to Support Urologist Participation in the AUA Quality Registry

  2/18/2021

  further advancing the science of urology, improving health care quality and ultimately improving the lives of the millions of people affected by prostate cancer, bladder cancer and other urologic disease.

• AmerisourceBergen Reports Fiscal 2021 First Quarter Results

  2/4/2021

  AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year to $52.5 billion.

• AmerisourceBergen Announces Quarterly Dividend

  1/14/2021

  AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021.

• AmerisourceBergen Expands Commitment to Diversity and Inclusion as a Company Priority with Appointment of New SVP and Chief Diversity & Inclusion Officer, Dr. Lonie Haynes

  11/9/2020

  As part of its commitment to fostering a diverse and inclusive culture, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Dr. Lonie Haynes as the company’s SVP and Chief Diversity & Inclusion Officer.

• AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine

  11/6/2020

  AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine VALLEY FORGE, Pa.--( BUSINESS WIRE )-- AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination. To suppo

• AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results

  11/5/2020

  AmerisourceBergen Corporation reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent to $49.2 billion.

• ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices

  10/5/2020

  The connected workflow platform helps specialty practices manage the financial assistance process in a comprehensive, yet streamlined way

• Good Neighbor Pharmacy Hosts First Virtual ThoughtSpot 2020 Conference & Trade Show

  9/15/2020

  The annual event, which convenes thousands of independent community pharmacies, moves to an immersive virtual environment on AmerisourceBergenLive.com

• AmerisourceBergen Reports Fiscal 2020 Third Quarter Results

  8/5/2020

  AmerisourceBergen Corporation reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion.

• MWI Animal Health Announces New Offerings to Alleviate Financial Burdens of Pet Care

  7/6/2020

  Two flexible financing solutions make essential pet care more affordable in the wake of COVID-19

• AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2020 Earnings Release

  7/2/2020

  AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2020 on Wednesday, August 5, 2020, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2020. Participating in the conference call will be: Steven H. Collis, Chairman, President & Ch

• AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™

  5/26/2020

  AmerisourceBergen, a global healthcare solutions leader, announced today that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization approach for QINLOCK which was approved by the U.S. Food and Drug Administration (FDA) on Friday, May 15, 2020. QINLOCK is an orally administered kinase switch control inhibitor approved for

• AmerisourceBergen Closes $500 Million Senior Note Offering - May 19, 2020

  5/19/2020

  AmerisourceBergen Corporation announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030, in an underwritten registered public offering.

• AmerisourceBergen Reports Fiscal 2020 Second Quarter Results

  5/7/2020

  AmerisourceBergen Corporation reported that in its fiscal year 2020 second quarter ended March 31, 2020, revenue increased 9.5 percent to $47.4 billion.